{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:52:14Z","timestamp":1791035534450,"version":"4.1.0"},"reference-count":68,"publisher":"Japan Academy","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Proc. Jpn. Acad., Ser. B","Proceedings of the Japan Academy. Ser. B: Physical and Biological Sciences"],"published-print":{"date-parts":[[2011]]},"DOI":"10.2183\/pjab.87.13","type":"journal-article","created":{"date-parts":[[2011,2,10]],"date-time":"2011-02-10T06:06:08Z","timestamp":1297317968000},"page":"13-28","source":"Crossref","is-referenced-by-count":321,"title":["Ivermectin, 'Wonder drug' from Japan: the human use perspective"],"prefix":"10.2183","volume":"87","author":[{"given":"Andy","family":"CRUMP","sequence":"first","affiliation":[{"name":"The Kitasato Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"OMURA","sequence":"additional","affiliation":[{"name":"The Kitasato Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"993","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/nrmicro1048","volume":"2","author":"Omura, S. and Crump, A.","year":"2005","journal-title":"Nat. Rev. Microbiol.","ISSN":"https:\/\/id.crossref.org\/issn\/1740-1526","issn-type":"print"},{"key":"2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijantimicag.2007.08.023","volume":"31","author":"Omura, S.","year":"2008","journal-title":"Int. J. Antimicrob. Agents","ISSN":"https:\/\/id.crossref.org\/issn\/0924-8579","issn-type":"print"},{"key":"3","unstructured":"3) Campbell, W.C. (1992) The genesis of the antiparasitic drug ivermectin. <i>In<\/i> Inventive Minds (eds. Weber, R.J. and Perkins, D.N.). Oxford University Press, New York, pp. 194&ndash;214."},{"key":"4","unstructured":"4) Frost, L., Reich, M.R. and Fujisaki, T. (2002) A partnership for ivermectin: Social Worlds and Boundary Objects. <i>In<\/i> Public-Private: Partnerships for Public Health (ed. Reich, M.R.). Harvard University Press, Cambridge, Mass., pp. 87&ndash;114."},{"key":"5","unstructured":"5) Tavis, L.A. (1997) River Blindness: The Merck Decision to Develop and Donate MECTIZAN. <i>In<\/i> Power and Responsibility: Multinational Managers and Developing Country Concerns. University of Notre Dame Press, Indiana, pp. 87&ndash;113."},{"key":"6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1179\/136485908X337481","volume":"102","author":"Thylefors, B.","year":"2008","journal-title":"Ann. Trop. Med. Parasitol.","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4983","issn-type":"print"},{"issue":"3","key":"7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/AAC.15.3.361","volume":"15","year":"1979","journal-title":"Antimicrob. Agents Chemother.","ISSN":"https:\/\/id.crossref.org\/issn\/0066-4804","issn-type":"print"},{"issue":"3","key":"8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/AAC.15.3.368","volume":"15","year":"1979","journal-title":"Antimicrob. Agents Chemother.","ISSN":"https:\/\/id.crossref.org\/issn\/0066-4804","issn-type":"print"},{"issue":"3","key":"9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1128\/AAC.15.3.372","volume":"15","year":"1979","journal-title":"Antimicrob. Agents Chemother.","ISSN":"https:\/\/id.crossref.org\/issn\/0066-4804","issn-type":"print"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1021\/jm00184a014"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1126\/science.6308762"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Burg, R.W. and Stapley, E.O. (1989) Isolation and characterization of the producing organism. <i>In<\/i> Ivermectin and Abamectin (ed. Campbell, W.C.). Springer, New York, pp. 24&ndash;32.","DOI":"10.1007\/978-1-4612-3626-9_2"},{"key":"13","unstructured":"13) Grisi, L., Massard, C.L., Moya-Borja, G.E. and Pereira, J.B. (2002) Impacto econ&ocirc;mico das principais ectoparasitoses em bovinos no Brasil. Hora Veterin&aacute;ria <b>21<\/b>, 8&ndash;10."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Ottesen, E. and Campbell, W. (1994) Ivermectin in human medicine. J. Antimicrob. Chemother. <b>34<\/b>, 195&ndash;203.","DOI":"10.1093\/jac\/34.2.195"},{"key":"15","first-page":"20","author":"Eckholm, E.","year":"1989","journal-title":"N.Y. Times Mag.","ISSN":"https:\/\/id.crossref.org\/issn\/0028-7822","issn-type":"print"},{"key":"16","unstructured":"16) UNESCO (2005) World Science Report (2005) UNESCO, Paris, p. 198."},{"key":"17","unstructured":"17) WHO (2010) Onchocerciasis (http:\/\/www.who.int\/topics\/onchocerciasis\/en\/)."},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1126\/science.2218502"},{"key":"19","unstructured":"19) WHO (1995) Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control Technical Report Series, No. 852 World Health Organization, Geneva, pp. 1--110."},{"key":"20","unstructured":"20) WHO\/TDR (1995) Tropical Disease Research: Progress 1975&ndash;94. WHO, Geneva, p. 95."},{"key":"21","unstructured":"21) Denham, D.A. and Barrett, J. (1987) The chemotherapy of filarial nematode infections of man: aspirations and problems. <i>In<\/i> Chemotherapy of Tropical Diseases: The problem and the challenge (ed. Hooper, M.). John Wiley &amp; Sons. Ltd., pp. 45&ndash;68."},{"key":"22","first-page":"271","volume":"56","author":"Duke, B.O.","year":"1962","journal-title":"Trans. R. Soc. Trop. Med. Hyg.","ISSN":"https:\/\/id.crossref.org\/issn\/0035-9203","issn-type":"print"},{"key":"23","first-page":"447","volume":"28","author":"Duke, B.O.","year":"1977","journal-title":"Tropenmed. Parasitol.","ISSN":"https:\/\/id.crossref.org\/issn\/0303-4208","issn-type":"print"},{"key":"24","unstructured":"24) Fujisaki, T. and Reich, M. (1998) TDR&rsquo;s contribution to the development of ivermectin for onchocerciasis. TDR, Geneva (TDR\/ER\/RD\/98.3)."},{"key":"25","unstructured":"25) WHO\/TDR (1976) Participation of the Pharmaceutical sector (TDR\/WP\/76.30)."},{"key":"26","unstructured":"26) Lucas, A.O. (2002) Public-private partnerships: illustrative examples. <i>In<\/i> Public-Private Partnerships for Public Health (ed. Reich M.). Harvard University Press, Cambridge, Mass., pp. 19&ndash;39."},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.45.1.445"},{"key":"28","unstructured":"28) Sturchio, J.L. (1992) The Decision to Donate Mectizan: Historical Background. Merck &amp; Co., Inc. Rahway, New Jersey, USA (unpublished document)."},{"issue":"8291","key":"29","first-page":"171","volume":"2","year":"1982","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"30","first-page":"681","volume":"76","author":"Coulaud, J.P., Larivi&egrave;re","year":"1983","journal-title":"Bull. Soc. Pathol. Exot. Filiales","ISSN":"https:\/\/id.crossref.org\/issn\/0037-9085","issn-type":"print"},{"key":"31","unstructured":"31) Telex from Robert D. Fluss of Merck &amp; Co. Inc&rsquo;s Division of International Public Affairs sent to the Director of WHO\/TDR, Dr Adetokunbo Lucas, on 20 June, 1986."},{"key":"32","unstructured":"32) Campbell, W.C. (2010) History of avermectin and ivermectin, with notes on the history of other macrocyclic lactone antiparasitic agents. <i>In<\/i> The Chemotherapy of Parasitic Diseases: Macrocyclic Lactones. Curr. Pharm. Biotechnol. <b>11<\/b> (In press)."},{"key":"33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/00034983.1980.11687330","volume":"74","author":"Awadzi, K.","year":"1980","journal-title":"Ann. Trop. Med. Parasitol.","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4983","issn-type":"print"},{"key":"34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/bjo.71.2.78","volume":"71","author":"Dadzie, K.Y., Bird, A.C., Awadzi, K","year":"1987","journal-title":"Br. J. Ophthalmol.","ISSN":"https:\/\/id.crossref.org\/issn\/0007-1161","issn-type":"print"},{"key":"35","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0140-6736(85)91496-5","volume":"326","author":"Larivi&egrave;re, M., Aziz, M.,","year":"1985","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"36","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(87)92291-4","author":"Diallo, S., Aziz, M.A., Ndir, O., B","year":"1987","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"37","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1001\/jama.259.21.3150","volume":"259","author":"Kumaraswami, V., Ottesen, E.A. and","year":"1988","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"38","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJM199004193221604","volume":"322","author":"Ottesen, E.A., Kumaraswami, V. and","year":"1990","journal-title":"N. Engl. J. Med.","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Richards, F.O. Jr., Eberhard, M.L., Bryan, R.T., Mcneeley, D.F., Lammie, P.J., Mcneeley, M.B., Bernard, Y., Hightower, A.W. and Spencer, H.C. (1991) Comparison of high-dose ivermectin and diethylcarbamazine for activity against Bancroftian filariasis in Haiti. Am. J. Trop. Med. Hyg. <b>44<\/b>, 3&ndash;10.","DOI":"10.4269\/ajtmh.1991.44.3"},{"key":"40","unstructured":"40) WHO (1997) World Health Assembly Resolution WHA 50.29 (http:\/\/www.who.int\/lymphatic_filariasis\/resources\/WHA_50%2029.pdf)."},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Turner, M. and Schaeffer, J.M. (1989) Mode of action of ivermectin. <i>In<\/i> Ivermectin and Avermectin (ed. Campbell, W.). Springer-verlag, New York, pp. 73&ndash;88.","DOI":"10.1007\/978-1-4612-3626-9_5"},{"key":"42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0169-4758(85)90100-0","volume":"1","author":"Campbell, W.C.","year":"1985","journal-title":"Parasitol. Today","ISSN":"https:\/\/id.crossref.org\/issn\/0169-4758","issn-type":"print"},{"key":"43","unstructured":"43) Omura, S. (2002) Mode of action of avermectin. <i>In<\/i> Macrolide antibiotics; Chemistry, Biology &amp; Practice (2nd Edition) (ed. Omura, S.). Academic Press, San Diego, pp. 571&ndash;575."},{"key":"44","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1046\/j.1365-2230.2002.01050.x","volume":"27","author":"del Mar Saez-De-Ocariz, M., McKinst","year":"2002","journal-title":"Clin. Exp. Dermatol.","ISSN":"https:\/\/id.crossref.org\/issn\/0307-6938","issn-type":"print"},{"key":"45","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0169-4758(91)90093-4","volume":"7","author":"Maizels, R.M. and Lawrence, R.A.","year":"1991","journal-title":"Parasitol. Today","ISSN":"https:\/\/id.crossref.org\/issn\/0169-4758","issn-type":"print"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Taylor, H.R. and Greene, B.M. (1989) The status of ivermectin in the treatment of human onchocerciasis. Am. J. Trop. Med. Hyg. <b>41<\/b>, 460&ndash;466.","DOI":"10.4269\/ajtmh.1989.41.460"},{"key":"47","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/infdis\/172.1.204","volume":"172","author":"Plaisier, A.P., Alley, E.S., Boatin","year":"1995","journal-title":"J. Infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"48","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1473-3099(08)70099-9","volume":"8","author":"Bas&aacute;&ntilde;ez, M.-G","year":"2008","journal-title":"Lancet Infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/1473-3099","issn-type":"print"},{"key":"49","first-page":"25","volume":"42","author":"Duke, B.O., Soula, G., Zea-Flores,","year":"1991","journal-title":"Trop. Med. Parasitol.","ISSN":"https:\/\/id.crossref.org\/issn\/0177-2392","issn-type":"print"},{"key":"50","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2883-2-S1-S5"},{"key":"51","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1011983107"},{"key":"52","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1371\/journal.pntd.0000217","volume":"2","author":"Allen, J.E., Adjei, O., Bain, O., H","year":"2008","journal-title":"PLoS Negl. Trop. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/1935-2727","issn-type":"print"},{"key":"53","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.pt.2004.08.001","volume":"20","author":"Kaplan, R.M.","year":"2004","journal-title":"Trends Parasitol.","ISSN":"https:\/\/id.crossref.org\/issn\/1471-4922","issn-type":"print"},{"key":"54","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.6.2674"},{"key":"55","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.pt.2004.07.010","volume":"20","author":"Wolstenholme, A.J.","year":"2004","journal-title":"Trends Parasitol.","ISSN":"https:\/\/id.crossref.org\/issn\/1471-4922","issn-type":"print"},{"key":"56","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1371\/journal.pntd.0000076","volume":"1","author":"Lustigman, S. and McCarter, J.P.","year":"2007","journal-title":"PLoS Negl. Trop. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/1935-2727","issn-type":"print"},{"key":"57","unstructured":"57) Omura, S. and Crump, A. (2009) Community-directed intervention: replicating Japan&rsquo;s health successes in Africa? <i>In<\/i> Innovating for the health of all. Global Forum Update on Research for Health (6), Global Forum for Health Research, Geneva, pp. 87&ndash;90."},{"key":"58","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2005.08.014"},{"key":"59","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.bmc.2008.12.003","volume":"17","author":"dos Santos, A.R., Falc&atilde;o","year":"2009","journal-title":"Bioorg. Med. Chem.","ISSN":"https:\/\/id.crossref.org\/issn\/0968-0896","issn-type":"print"},{"key":"60","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1016\/j.bmc.2008.12.069","volume":"17","author":"Pitterna, T., Cassayre, J., H&u","year":"2009","journal-title":"Bioorg. Med. Chem.","ISSN":"https:\/\/id.crossref.org\/issn\/0968-0896","issn-type":"print"},{"key":"61","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1371\/journal.pntd.0000293","volume":"2","author":"Moncayo, A.L., Vaca, M., Amorim, L.","year":"2008","journal-title":"PLoS Negl. Trop. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/1935-2727","issn-type":"print"},{"key":"62","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/0035-9203(91)90255-W","volume":"85","author":"Dunne, C.L., Malone, C.J. and Whitw","year":"1991","journal-title":"Trans. R. Soc. Trop. Med. Hyg.","ISSN":"https:\/\/id.crossref.org\/issn\/0035-9203","issn-type":"print"},{"key":"63","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0001-706X(99)00087-X","volume":"75","author":"Bockarie, M.J., Alexander, N.D., Ka","year":"2000","journal-title":"Acta Trop.","ISSN":"https:\/\/id.crossref.org\/issn\/0001-706X","issn-type":"print"},{"key":"64","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0065-308X(08)60151-7","volume":"42","author":"Albonico, M., Crompton, D.W. and Sa","year":"1999","journal-title":"Adv. Parasitol.","ISSN":"https:\/\/id.crossref.org\/issn\/0065-308X","issn-type":"print"},{"key":"65","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(04)15738-3","volume":"363","author":"Heukelbach, J.","year":"2004","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"66","unstructured":"66) Heukelbach, J., Winter, B., Wilcke, T., Muehlen, M., Albrecht, S., de Oliviera, F.A., Kerr-Pontes, L.R., Liesenfeld, O. and Feldmeier, H. (2004) Selective mass treatment with ivermectin to control intestinal helminthiasis and parasitic skin diseases in a severely affected population. Bull. World Health Organ. <b>82<\/b> (8), 559&ndash;636."},{"key":"67","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nrmicro2345","volume":"8","year":"2010","journal-title":"Nat. Rev. Microbiol.","ISSN":"https:\/\/id.crossref.org\/issn\/1740-1526","issn-type":"print"},{"key":"68","unstructured":"68) Speare, R. and Durrheim, D. (2004) Mass treatment with ivermectin: an underutilized public health strategy. Bull. World Health Organ. <b>82<\/b> (8), 559&ndash;636."}],"container-title":["Proceedings of the Japan Academy, Series B"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/pjab\/87\/2\/87_2_13\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T05:04:19Z","timestamp":1621573459000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/pjab\/87\/2\/87_2_13\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2183\/pjab.87.13","relation":{},"ISSN":["0386-2208","1349-2896"],"issn-type":[{"value":"0386-2208","type":"print"},{"value":"1349-2896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}